Table 1

Demographic and clinical data in patients with progressive supranuclear palsy (PSP) and controls

Group (n)Age (years)UPDRS-IIIDD (years)L-Dopa response: No or poor/moderate/good
Values are mean (SD) or n.
DD, disease duration; UPDRS-III, unified Parkinson’s disease rating scale – motor examination.
PSP (12)67.5 (6.6)38.9 (10.9)2.7 (0.9)11/1/0
Controls (12)60 (5.8)